CURRICULUM VITAE: Dott. Carlo Salvarani Data di nascita: 14

1
CURRICULUM VITAE: Dott. Carlo Salvarani
Data di nascita: 14 novembre 1954.
Luogo di nascita: Reggio Emilia, Italia.
Indirizzo:
Casa: Via Dal Verme N3, 42100 Reggio Emilia, Italia.
Lavoro: Servizio di Reumatologia, Azienda Ospedaliera Arcispedale S.Maria Nuova,
V.le Risorgimento N 90, 42100 Reggio Emilia, Italia.
Titoli:
Laurea in Medicina, 1980, Università di Parma.
Specialista in Medicina Interna, 1985, Università di Parma.
Specialista in Reumatologia, 1989, Università di Ferrara.
Onori:
Laurea, Magna cum Laude, 1980, Università di Parma.
Specialista in Reumatologia, Magna cum Laude, 1989, Università di Ferrara.
Speaker invitato (1997), Divisione di Reumatologia, Mayo Clinico
Presidente 8th International Congress on Behçet's disease (Reggio Emilia 1998)
Attività Postlaurea (per specifiche attività lavorativa nel Servizio Sanitario vedi
allegato stato di servizio):
1980-81: Interno, 2" Divisione di Medicina Interna, Arcispedale S.Maria Nuova, Reggio
Emilia.
1981-82: Assistente a tempo pieno, Divisione di Medicina, Ospedale S.Anna, Castelnuovo
Monti
(RE).
1982-96: Assistente a tempo pieno, 2" Divisione di Medicina Interna, Unità
Reumatologica, Arcispedale . S.Maria Nuova, Reggio Emilia.
Dal 8-1-1993 al 7-1-1994 comandato presso la Divisione di Reumatologia, Mayo Clinic,
Rochester, MN, USA per aggiornamento in clinica e epidemiologia delle artriti
infiammatorie e vasculiti. Successivamente periodi periodi si studio della durata di 6-8
settimane negli anni 1994, 1995, 1996, 1998, 1999,2000,2001, 2003, 2004, 2006, 2007,
2008, 2009, 2010, 2011 come "Visiting Clinician" investigatore principale di progetti di
ricerca clinici sulle vasculiti (vedi per i progetti collaborazioni scientifiche)
1996- tutt'oggi: Medico 2 livello Dirigenziale Reumatologia e quindi Direttore, Struttura
Complessa di Reumatologia, Arcispedale S.Maria Nuova, Azienda Ospedaliera di Reggio
Emilia.
Attività didattica presso Scuole di Specialità
Per gli anni 2007-2008, 2008-2009, 2009-2010, 2011-2012 contratto insegnamento
integrativo “Le vasculiti dei grossi vasi” a titolo oneroso di ore 5 annuali presso la Scuola
di Specializzazione di Reumatologia dell’Università di Bologna
1
2
Società mediche di appartenenza:
Società Italiana di Reumatologia (membro del Consiglio Direttivo dal 2004 al 2007).
Società Italiana di Medicina Interna.
American College of Rheumatology (International Member).
Altre Attività:
Revisore di Riviste Internazionali:
Journal of Rheumatology
Clinical and Experimental Rheumatology
Arthritis & Rheumatism
Arthritis Care & Research
Scandinavian Joumal of Rheumatology
Rheumatology
The Annals of Rheumatic Diseases
Medicine
JAMA
Circulation
Lancet
New England Journal of Medicine
Editorial Board
Arthritis Care & Research
Clinical and Experimental Rheumatology (Editor of the Supplement on Vasculitides)
Current Opinion in Rheumatology
Principali interessi scientifici:
Vasculiti (in particolare arterite temporale, malattia di Takayasu, malattia di Behçet e
vasculite isolata del sistema nervoso centrale)
Spondiloartriti (in particolare artropatia psoriasica, artrite enteropatica e spondilite
anchilosante)
Polimialgia reumatica, sindrome RS3PE e artrite reumatoide dell'anziano
Trials clinici
Collaborazioni scientifiche attive (membro nazionale/internazionale):
Divisione di Reumatologia e Diagnostica Vascolare, Mayo Clinic, USA: Polimialgia
reumatica e Arterite Temporale
Divisioni di Reumatologia e Diagnostica Vascolare, Dipartimento di Patologia, Mayo Clinic,
USA: vasculite del sistema gastrointestinale
Divisioni di Reumatologia , Neurologia, e Diagnostica vascolare, Dipartimenti di Patologia
e di Statistica, Mayo Clinic, USA: Vasculite isolata del Sistema Nervoso Centrale
The European Collaborative Study on Inflammatory Bowel Disease: Manifestazioni
2
3
muscolo-scheletriche delle malattie infiammatorie intestinali
Progetto ITAKA (Italian Takayasu arteritis) (Mari Negri, Villa Camozzi): Arterite di
Takayasu nella popolazione Italiana
Polymyalgia Rheumatica and Giant CelI Arteritis Intemational Study Group: criteri
diagnostici della Polimialgia Reumatica
ASsessment in Ankylosing Spondylitis (ASAS) Working Group: definizione di criteri di
valutazione dell' efficacia della terapia nelle spondiloartriti
lntemational multicenter validation of diagnostic criteri a for psoriatic artbritis (CASPAR):
definizione e validazione dei criteri diagnostici per l' artropatia psoriasica
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
Raccomandazioni EULAR per la terapia della malattia di Behçet
Raccomandazioni EULAR per la terapia della vasculiti
EULAR and ACR Diagnostic and Classification criteria in vasculitis
Gruppo multidisciplinare sui farmaci biologici in Reumatologia Regione Emilia Romagna
con definizione di registro regionale
3
4
Articoli su riviste con Impact Factor:
1. A.Bellelli, B.Tumiati, C.Salvarani et al.: Sindrome di Reynolds. Caso clinico e revisione
della letteratura. Analogia con GVHD. Giornale di Clinica Medica, 62:656-64,1981.
2. A.Bellelli, C.Azzarito, C.Salvarani et al.:.Sarcoma di Kaposi in corso di terapia
cortisonica. Descrizione di un caso clinico. Giornale di Clinica Medica, 63:614-21,1982.
3. I.Portioli, C.Fantesini, C.Salvarani et al.: Morbo di Paget del cranio complicato da
demenza idrocefalica: diagnosi precoce con la TAC cerebrale e remissione dopo
intervento chirurgico. Medicina, 3:44-6, 1983.
4. C.Salvarani, I.Iori, F .Rossi et al.: Neurologic involvement as ftrst sign ofBeh~et's
syndrome. Clin Exp Rheumatol, 2:353-4, 1984.
5. C.Salvarani, I.Iori, F .Rossi et al: Hypersensitivity to diclofenac with acute hepatitis,
immune-hemolitic anemia, thrombocytopenia and renal involvement. Ital Joumal
Gastroenterol, 16:54-6, 1984.
6. C.Salvarani, PL.Macchioni, F .Rossi et al.: Nephrotic syndrome induced by tiopronin:
association with HLA-DR3 antigen. Arthritis Rheum, 28:595-6, 1985.
7. C.Salvarani, l.Iori, S.Prandi et al: Gold-induced severe apI asti c anemia: medullary
autologous reconstitution after immunosuppression. J Rheumatol, 2:387, 1985.
8. C.Salvarani, G.Massai, PL.Macchioni et al: Infarto cerebrale e trombocitopenia in un
caso fatale di LES cerebrale: associazione con anticorpi anticardiolipina e lupus
anticoagulante. Medicina, 5:426-7, 1985.
9. C.Salvarani, PL.Macchioni, F .Rossi et al.: HLA typing, platelet associated
immunoglobulins and anticardiolipin antibodies. J Rheumatol, 5:988-90, 1986.
10. C.Salvarani, G.Massai, PL.Macchioni et al.: Anticardiolipin antibodies in a case
ofNeuro-Behçet with superior vena cavaI occlusion. Clin Rheumatol, 1:88-91, 1987.
11. C.Salvarani, PL.Macchioni, PL. Tartoni et al.: Polymyalgia rheumatica and giant celI
arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp
Rheumatol, 5:205-15, 1987.
12. C.Salvarani, PL.Macchioni, F.Rossi et al.: Synovitis in polymyalgia rheumatica: a 5year followup study in Reggio Emilia, Italy. J Rheumatol, 14:1209-10, 1987.
13. C.Salvarani, PL.Macchioni, F.Rossi et al.: Arterite giganto-cellulare: uno studio
epidemiologico, clinico e patologico durante un periodo di 5 anni in Reggio Emilia.
Reumatismo, 40:113-6, 1988.
14. C.Salvarani, L.Ghirelli, C. Di Lecce et al.: Differenti quadri capillaroscopici, clinici ed
anticorpali nei pazienti con fenomeno di Raynaud. Reumatismo, 40:183-6,1988.
4
5
15. C.Salvarani, N.Marcello, PL.Macchioni et al.: Hypothyroidism simulating polymyositis.
Scand J Rheumatol, 17:147-9, 1988.
16. C.Salvarani, PL.Macchioni, F .Zizzi et al.: Clinical subgroups and HLA antigens in
Italian patients with psoriatic arthritis. Clin Exp Rheumatol, 7:391-6, 1989.
17. C.Salvarani, N.Capozzoli, R.Baricchi et al.: Autoimmune disease in hairy-cellleukemia:
systemic vasculitis and anticardiolipin syndrome. Clin Exp Rheumatol, 7:329-30,1989.
18. C.Salvarani, F .Zizzi, PL.Macchioni et al.: Clinical response to auranofm in patients
with psoriatic arthritis. Clin Rheumatol, 8:54-7,1989.
19. C.Salvarani, F.Rossi, PL.Macchioni et al.: Bartter's syndrome and chondrocalcinosis: a
possible role far hypomagnesemia in the deposition of calcium pyrophosphate dihydrate
(CPPD) crystals. Clin Exp Rheumatol, 7:415-20,1989.
20. P.Sottilotta, C.Salvarani, M.Veneziani et al.: Aspetti psicosociali a disabilità al lavoro
nell'artrite reumatoide: studio su un campione di pazienti della provincia di Reggio Emilia.
Reumatismo, 42:192-5, 1990.
21. C.Salvarani, PL.Macchioni, F.Zizzi et al.: Low incidence ofproteinuria in RA after gold
thiosulfate treatment. JRheumatol., 17:271-2, 1990.
22. C.Salvarani, PL.Macchioni, M. Veneziani et al: Upper limb lymphedema in psoriatic
arthritis. J Rheumatol., 17:273-4, 1990.
23. C.Salvarani, F .Zizzi, PL.Macchioni, et al.: Uno studio clinico dell'artrite reumatoide
dell'anziano. Confronto con un gruppo di pazienti con malattia insorta prima dei 60 anni. Il
Reumatologo, 3:107-112;1990.
24. C.Salvarani, PL.Macchioni, F.Zizzi et al.: Reply to: Low incidence oftoxicity from gold
thiomalate in Hong Kong chinese patients with rheumatoid arthritis. J Rheumatol, 18:63032, 1991.
25. C.Salvarani, B.Casali, D.Salvo et al.: The role of interleukin 1, erythropoietin and red
cells bound immunoglobulins in the anaemia ofrheumatoid arthritis. Clin. Exp. Rheumatol.,
9:241-246,1991.
26. C.Salvarani, PL.Macchioni, L.Lodi et al.: Sjogren's syndrome in human
immunodeficiency virus (HIV) infection: association with HLA-DR3 and CD8 lymphocytosis
in an ltalian patient. Clin. Exp. Rheumatol., 9:437-438, 1991.
27. C.Salvarani, D.Lasagni, B.Casali et al.: Recombinant human erythropoietin therapy in
patients with rheumatoid arthritis with the anemia of chronic disease. J Rheumatol18:
1168-71; 1991.
28. C.Salvarani, PL.Macchioni, F .Zizzi, et al.: Epidemiologic and immunogenetic aspects
of polymyalgia rheumatica and giant celI arteritis in Northem ltaly. Arthritis Rheum, 34:351-
5
6
356; 1991.
29. R.Baricchi, R.Carbognani, L.Vecchia, C.Salvarani, et al.:Determinazione degli
isoenzimi della fosfatasi alcalina
mediante elettroforesi su gel di agarosio in 13 pazienti affetti da sindrome di Sjogren
primitiva. Notiziario Clinico, 4: 17- 19; 1991.
30. C.Salvarani, PL.Macchioni, T.Cremonesi et al.: The cervical spine in psoriatic arthritis:
a clinical, radiological and immunogenetic study. Ann. Rheum. Dis., 51:73-77,1992.
31. C.Salvarani, PL.Macchioni, L.Boiardi et al.: Low dose cyclosporine A in psoriatic
arthritis: relation between soluble interleukin 2 receptors and response to therapy. J
Rheumatol, 19:74-79,1992.
32. L.Boiardi, C.Salvarani, PL.Macchioni, et al.: Immunologic effects in patients with
psoriatic arthritis treated with cyclosporine A. J Rheumatol, 19:1933-37; 1992.
33. C.Salvarani, R.Baricchi, PL.Macchioni, et al.: Anticardiolipin antibodies in Northem
ltalian population with PMR/GCA. Aro J Med, 92:712-713; 1992.
34. R.Baricchi, L.Boiardi, C.Salvarani, et al.: Anticorpi anticardiolipina e ischemia
miocardica. Il Patologo Clinico, 7:614-617; 1992.
35. C.Salvarani, PL.Macchioni, L.Boiardi, et al.: Soluble interleukin 2 receptors in
polymyalgia rheumatica/giant celI arteritis. Clinical and Laboratory correlations. J
RheumatoI19:1100-1106; 1992.
36. C.Salvarani, PL.Macchioni, W.Mantovani et al.: Extraarticular manifestations of
rheumatoid arthritis and HLA antigens in Northem ltaly. J Rheumatol, 19:242-46, 1992.
37. C.Salvarani, F .Rossi, PL.Macchioni et al.: Synovitis in polymyalgia rheumatica: an
immunogenetic study. Brit J Rheumatol, 1:720; 1992.
38. C.Salvarani, PL.Macchioni, L.Boiardi et al.: Reply to Gonzalez-Gay et al. letter on"
Temporal arteritis in Northwestern Spain". Arthritis Rheum (letter), 35:1250,1992.
39. C.Salvarani, PL.Macchioni, W.Mantovani et al.: Polymyalgia rheumatica and
seronegative rheumatoid arthritis: some considerations based on a Northem Italian
population. J Rheumatol, 20:756-57, 1993.
40. C.Salvarani, L.Boiardi, M.Casadei Maldini, et al.: High dose immunoglobulin therapy in
a case of inclusion body myositis: clinical and immunologic aspects. J Rheumatol,
20:1455-56; 1993.
41. C.Salvarani, B.Casali, L.Boiardi, et al.: Low molecular weight IgM in primary Sjogren's
syndrome. Clin Exp Rheumatol 639-642,1993.
42. PL.Macchioni, L.Boiardi, C.Salvarani et al.: Lymphocyte subpopulations analysis in
peripheral blood in polymyalgia rheumatica/giant celI arteritis. Br J Rheumatol, 32:66-670,
6
7
1993.
43. C. Salvarani: L'anemia nell'artrite reumatoide. Il Reumatologo, 14:229-231; 1993.
44. L.Boiardi, P .Macchioni, C.Salvarani, et al.: Se rum soluble interleukin-2 receptor
levels in rheumatoid arthritis: corre la ti o n with clinical and immunological parameters and
with the response to auranofm treatment. Clin Exp Rheumatol, 12:357-362, 1994.
45. C.Salvarani, L.Boiardi, PL.Macchioni, et al.: Serum soluble CD4 and CD8 levels in
polymyalgia rheumatica. JRheumatol, 21:1865-69,1994.
46. PL.Macchioni, L.Boiardi, R.Meliconi, C.Salvarani, et al.: Elevated soluble intercellular
adhesion mole cuI e 1 in the serum of patients with polymyalgia rheumatica: influence of
steroid treatment. J Rheumatol, 21: 1860-64; 1994.
47. C.Salvarani, SE Gabriel, MA Gertz et al.: Primary systemic amyloidosis presenting as
giant celI arteritis and polymyalgia rheumatica. Arthritis Rheum, 37:1621-26, 1994.
48. P.Nurchis, C.Salvarani, F.Zizzi et al.: Rheumatoid arthritis in the elderly: frequency
ofside effects ofparenteral and oral chrysotherapy. Eur J Int Med, 5:27-32, 1994.
49. C.Salvarani, SE Gabriel, WM O'FalIon, GG Hunder: Epidemiolgy ofpolymyalgia
rheumatica in OIrosted County, Minnesota, 1970-1991. Arthritis Rheum, 38:369-73,1995.
50. C.Salvarani: Upper limb lymphedema in inflammatory arthropathy. J Rheumatol,
22:370, 1995.
51. C.Salvarani, L.Boiardi, PL.Macchioni et al.: On the utility of CD8 levels assessment in
the diagnosis of polymyalgia rheumatica/giant celI arteritis. Clin Exp Rheumatol, 13:12930, 1995.
52. C.Salvarani, L.Boiardi, PL.Macchioni, et al.: The role ofperipheral CD8+ lymphocytes
and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in
polymyalgia rheumatica and giant celI arteritis, Ann Rheum Dis, 54:640-44,1995.
53. C.Salvarani, SE Gabriel, WM O'Fallon, GG Hunder: The incidence of giant celI arteritis
in OIrosted County, Minnesota, apparent fluctuations in a cyclic pattem. Ann Intem Med,
123:192-194, 1995.
54. Salvarani, G. Lo Scocco, PL. Macchioni, et al.: Prevalence ofpsoriatic arthritis in Italian
psoriatic patients. J Rheumatol, 12:1499-1503, 1995.
55. C.Salvarani, R.Baricchi, D.Lasagni et al.: Chronic disease anemia associated with
rheumatoid arthritis: effects of desferrioxamine therapy on anemia and clinical status.
Rheumatology Intemational, 16:45-48, 1996.
56. R. Meliconi, C.Salvarani, PL. Macchioni, et al.: Leucocyte infiltration in synovial tissue
from the shoulder of patients with polymyalgia rheumatica. Arthritis Rheum, 39:1199-1206,
1996.
7
8
57. C.Salvarani, S.Gabriel, GG.Hunder: Reply. Giant cell arteritis and amyloidosis:
comment on the article by Salvarani et al. Arthritis Rheum, 39:1073, 1996.
58. L.Boiardi, C.Salvarani, PL.Macchioni et al.: CD8 lymphocyte subsets in active
polymyalgia rheumatica: comparison with elderly-onset and adult rheumatoid arthritis and
influence of prednisone therapy. Br J Rheumatol, 35:642-48, 1996.
59. C.Salvarani, L.Boiardi, PL.Macchioni et al.: Polymyalgia rheumatica. Lancet, 348:550551,1996.
60. C.Salvarani, S.Gabriel, GG.Hunder: DistaI extremity swelling with pitting edema in
polymyalgia rheumatica. Report ofnineteen cases. Arthritis Rheum, 3'9:73-80,1996.
61. C.Salvarani, S.Gabriel, GG.Hunder: Reply. Il Comparison of polymyalgia rheumatica
and remitting seronegative symmetrical synovitis with pitting edema syndrome: comment
on the article by Salvarani et al. Arthritis Rheum, 39:1931-1932,1996.
62. C. Salvarani, I. Olivieri, F .Cantini, L.Barozzi: E' la sindrome "RS3PE" una entità
autonoma. Reumatismo, 48:201-204, 1996.
63. M.Massari, C.Salvarani, I.Portioli, et al.: Polyarteritis nodosa and mv infection: no
evidence of a direct pathogenic role of HIV. Infection, 24:159-61,1996.
64. I.Olivieri, C.Salvarani, F.Cantini: Remitting distaI extremity swelIing with pitting edema:
a distinct syndrome or a clinical feature of different inflammatory rheumatic diseases? J
Rheumatol, 24:249-52; 1997.
65. C.Salvarani, F .Cantini, I.Olivieri et al.: Isolated peripheral enthesitis andlor dactylitis: a
subset of psoriatic arthritis. J Rheumatol, 24:1106-10; 1997.
66. C.Salvarani, F.Cantini, I.Olivieri et al.: Proximal bursitis in active polymyalgia
rheumatica. Ann Intem Med, 127:27-31, 1997.
67. C.Salvarani, PL Macchioni, L.Boiardi: Polymyalgia rheumatica. Lancet, 350:43-47,
1997.
68. F.Cantini, L.Emmi, C.Salvarani, et al.: Lack of association between chronic hepatitis c
virus infection and Behçet's disease. Clio Exp Rheumatol, 15:338-339, 1997.
69. SE Gabriel, J Sunku, C.Salvarani et al.: Long-term outcome of anti-inflammatory
therapy among patients with polymyalgia rheumatica. Arthritis Rheum, 40: 1873-8, 1997.
70. R.Meliconi, L.PulsatelIi, C.Salvarani, et al.: Synovial expression of celI adhesion
molecules in polymyalgia rheumatica. ClinExplmmunol; 107:494-500, 1997.
71. I.Olivieri, F.Cantini, C.Salvarani: Diagnostic and classification criteria for
spondyloarthropathies, clinical and functional assessment, and therapeutic advances. Curr
Opin Rheumatol; 9:284-90, 1997.
8
9
72. I.Olivieri, C.Salvarani, F. Cantini, et al.: Therapy with cyclosporine in psoriatic arthritis.
Semin Arthritis Rheum ; 27:36-43, 1997.
73. I.Olivieri, C.Salvarani, F .Cantini: Is Behçet's disease part of spondyloarthritis
complex? J Rheumatol; 24:1870-2, 1997.
74. F.Cantini, L.Niccoli, C.Salvarani, et al.: Remitting distaIlower extremity swelIing with
pitting oedema in acute sarcoidosis. Ann Rheum Dis; 56:565-6, 1997.
75. I.Olivieri, C.Salvarani, F .Cantini et al.: DistaI extremity swelIing with pitting edema in
polymyalgia rheumatica: a case studied with MRI. Clin Exp Rheumatol; 15:710-1, 1997.
76. C.Salvarani, PL.Macchioni, W.Mantovani et al.: HLA-DRBI alleles associated with
rheumatoid arthritis in Northem ltaly. Correlation with disease severity. British J
Rheumatol; 37:165-9, 1998.
77. F .Cantini, I.Olivieri, C.Salvarani: More on remitting seronegative symmetrical synovitis
with pitting edema as a paraneoplastic syndrome: J Rheumatol; 25:188-9,1998.
78. P .Macchioni, L.Boiardi, C.Salvarani, et al.: Serum chemokines in patients with
psoriatic arthritis treated with cyclosporin A. J Rheumatol; 25:320-5, 1998.
79. F .Cantini, C.Salvarani, I.Olivieri et al.: Possible association between eosinophilic
fasciitis and subcutaneous heparin use. J Rheumatol; 25:383-5, 1998.
80. A.Padula, C.Salvarani, L.Barozzi, et al: Dactylitis also involving the synovial sheaths in
the palm ofthe hand: two more cases studied by magnetic resonance imaging. Ann
Rheum Dis; 57:61-2,1998.
81. F .Cantini, C.Salvarani, I.Olivieri: Erythrocyte sedimentation rate and C-reactive
protein in the diagnosis of polymyalgia rheumatica. Ann Intern Med; 128:873-4, 1998.
82. L.Pulsatelli, R.Meliconi, C.Salvarani, et al.: Elevated serum concentrations of the
chemokine RANTES in patients with polymyalgia rheumatica. Clin Exp Rheumatol;
16:263-8, 1998.
83. F .Cantini, C.Salvarani, I.Olivieri, et al.: Tuberculous spondylitis as a cause of
inflammatory spinal pain: a report of 4 cases. Clin Exp Rheumatol; 16:305-8, 1998.
84. C.Salvarani, F .Cantini, P .Macchioni, et al.: DistaI musculoskeletal manifestations in
polymyalgia rheumatica: a prospective followup study. Arthritis Rheum; 41:1221-6, 1998.
85. P .Macchioni, L.Boiardi, C.Salvarani, et al.: The relationship between serum-soluble
interleukin-2 receptor and radiological evolution in psoriatic arthritis patients treated with
cyclosporin-A. Rheumatol Int; 18:27-33, 1998.
86. I.Olivieri, L.Barozzi, C.Salvarani, et al.: Retrocalcaneal bursitis in spondyloarthropathy:
assessment by ultrasonography and magnetic resonance imaging. J Rheumatol; 25:13527,1998.
9
10
87. C.Salvarani, I.Olivieri, F.Cantini, et al.: Psoriatic arthritis. Curr Opin Rheumatol;
10:299-305, 1998.
88. F .Cantini, C.Salvarani, L.Niccoli, et al.: Behçet's disease with unusual cutaneous
lesions. J Rheumatol; 25:2469-72, 1998.
89. C.Salvarani, I.Olivieri, F.Cantini, GG. Hunder: Classification ofinflammatory arthritis.
Lancet; 352:1938,1998.
90. Salvarani C, Macchioni L, Olivieri I, Cantini F, Boiardi L. Diagnosis and management
of polymyalgia rheumatica/giant cell arteritis. BioDrugs. 1998; 9:25-32.
91. A.Padula, F .Belsito, C.Salvarani, et al.: Isolated tenosynovitis associated with
psoriasis triggered by physical injury. Clin Exp Rheumatol;
17:103-4, 1999.
92. C.Salvarani, F .Cantini, I. Olivieri, GG. Hunder: Polymyalgia rheumatica: a disorder of
extraarticular synovial structures. J Rheumatol; 26:517-21,1999.
93. C.Salvarani, L.Boiardi, V.Mantovani, et al.: HLA-DRBI alleles associated with
polymyalgia rheumatica in northem ltaly: correlation with disease severity. Ann Rheum
Dis; 58:303-8, 1999.
94. F.Cantini, C.Salvarani, I.Olivieri, et al.: Remitting seronegative symmetrical synovitis
with pitting oedema (RS3PE) syndrome: a prospective follow-up and magnetic resonance
imaging study. Ann Rheum Dis; 58:230-6,1999.
95. C.Salvarani, GG.Hunder: Musculoskeletal manifestations in a population-based cohort
ofpatients with giant celI arteritis. Arthritis Rheum; 42:1259-66, 1999.
96. MA. Gonzalez-Gay, C. Garcia-Porrua, C.Salvarani, GG. Hunder: Diagnostic approach
in a patient presenting with polymyalgia. Clin Exp Rheumatol; 17:276-8, 1999.
97. F.Cantini, C.Salvarani, L.Niccoli, et al: Treatment of thrombophlebitis of Behçet's
disease with low dose cyclosporin A. Clin Exp Rheumatol; 17:391-2, 1999.
98. C.Salvarani, F .Cantini, I.Olivieri, et al.: Distal extremity swelling with pitting edema in
psoriatic arthritis: evidence of 2 pathological mechanisms. J Rheumatol; 26:1831-4,1999.
99. L.Boiardi, P .Macchioni, C.Salvarani, et al.: Relationship between serum RANTES
levels and radiological progression in rheumatoid arthritis patients treated with
methotrexate. Clin Exp Rheumatol; 17:419-25, 1999.
100. F .Cantini, C.Salvarani, I.Olivieri, et al.: Hip bursitis in active polymyalgia rheumatica:
report of a case. Clin Exp Rheumatol; 17:512-3, 1999.
101. A.Padula, L.Barozzi, C.Salvarani, et al: Involvement oftransitionallumbosacraljoints in
10
11
spondyloarthritis. Clin Exp Rheumatol; 17:636-7, 1999.
102. C.Salvarani, L.Boiardi, V.Mantovani, et al.: HLA-DRBl, DQAl and DQBl alleles
associated with giant celI arteritis in northem Italy. J Rheumatol; 26:2395-9,1999.
103. F.Cantini, C.Salvarani, I.Olivieri: Shoulder sonographic fmdings in polymyalgia
rheumatica. J Rheumatol; 26:2501-2, 1999.
104. F .Cantini, C.Salvarani, I.Olivieri: Paraneoplastic remitting seronegative symmetrical
synovitis with pitting edema. Clin ExpRheumatol; 17: 741-4,1999.
105. C.Salvarani, K.Calamia, M.Silingardi, et al.: Thrombosis associated with the
prothrombin G-A20210 mutation in Behçet's disease. J Rheumatol; 27:515-6, 2000
106. C. Salvarani, B. Casali, L.Boiardi, et al.: Intercellular adhesion molecule 1 gene
polymorphisms in polymyalgia rheumatica/giant celI arteritis: association with disease risk
and severity. J Rheumatol; 27:1215-21, 2000.
107. C. Salvarani, F.Cantini, I. Olivieri, et al.: Corticosteroid injections in polymyalgia
rheumatica: a double-blind prospective, randomized, placebo-controlled study. J
Rheumatol ; 27: 1470-6,2000.
108. MA. Gonzalez-Gay, C. Garcia-Porrua, C.Salvarani, GG. Hunder: Cutaneous
vasculitis and cancer: a clinical approach. Clin Exp Rheumatol; 18:305-7, 2000.
109. M.Schirmer, KT. Calamia, C.Salvarani: First Intemational conference on polymyalgia
rheumatica and giant celI arteritis, Prato, Italy. May 25-26,1999. J Rheumatol; 27:1801-3,
2000.
110. P. Pavlica, L. Barozzi, C. Salvarani, et al: Magnetic resonance imaging in the
diagnosis of PMR. Clin Exp Rheumatol; 18:S38-9,2000.
111. C. Salvarani, F .Cantini, I.Olivieri: DistaI musculoskeletal manifestations in
polymyalgia rheumatica. Clin Exp Rheumatol; 18:S51-2, 2000.
112. I. Olivieri, C. Salvarani, F.Cantini: RS3PE syndrome: an overview. Clin Exp
Rheumatol; 18:S53-5, 2000.
113. F. Cantini, C. Salvarani, I. Olivieri, et al: Erythrocyte sedimentation rate and Creactive protein in the evaluation of disease activity and severity in polymyalgia
rheumatica: a prospective follow-up study. Semin Arthritis Rheum;30: 17-24, 2000.
114. MA. Gonzalez-Gay, C. Garcia-Porrua, C. Salvarani, et al: The spectrum of conditions
mimicking polymyalgia rheumatica in Northwestem Spain. J Rheumatol; 27:2179-84,
2000.
115. C. Salvarani, G. Fomaciari, M. Beltrami, et al: Musculoskeletal manifestations in
inflammatory bowel disease. Eur J Int Med; 210-14; 2000.
11
12
116. Cimmino MA., Salvarani C., Macchioni P., et al: Extra-articular manifestations in 587
Italian patients with rheumatoid arthritis. Rheumatol lnt; 19:213-7,2000.
117. Macchioni P., Boiardi L., Salvarani C., et al : Intercellular adhesion molecu1es 1
(ICAM-I) gene polymorphisms in Italian patients with rheumatoid arthritis. Clin Exp
Rheumatol ; 18 :553-8,2000.
118. Salvarani C., Boiardi T., Timms JM., et al : Absence of the association with CC
chemokine receptor 5 polymorphism in polymyalgia rheumatica. Clin Exp Rheumatol; 18
:591-5,2000.
119. Me1iconi R., Pu1satelli L., Sa1varani C., et al: Vascu1ar endothe1ia1 growth factor
production in po1ymyalgia rheumatica. Arthritis Rheum ; 43 :2472-80,2000.
120. Boiardi L., Salvarani C., Timms JM., et al: Inter1eukin-1 c1uster and tumor necrosis
factor-a1pha gene po1ymorphisms in polymya1gia rheumatica. C1in Exp Rheumatol ; 18
:675-81,2000.
121. Gonzalez-Gay MA., Garcia-Porrua C., Salvarani C., et al : Polymya1gia
manifestations in different conditions mimicking po1ymya1gia rheumatica. C1in Exp
Rheumato1; 18 :755-9,2000.
122. Salvarani C., Hunder GG. : Giant cell arteritis with low erythrocyte sedimentation rate:
frequency of occurrence in a population-based study. Arthritis Rheum; 45 :140-5,2001.
123. Cantini F., Salvarani C., Olivieri I., et al : Inflamed shou1der structures in
po1ymyalgia rheumatica with normal erythrocyte sedimentation rate. Arthritis Rheum ; 44 :
1155-9, 2001.
124. Cantini F., Salvarani C., Olivi eri I., et al : Shou1der u1trasonography in the diagnosis
of polymya1gia rheumatica : a case contro1 study. J Rheumato1; 28 :1049-55,2001.
125. Cantini F., Salvarani C., 01ivieri I., et al : Distai extremity swelling with pitting edema
in psoriatic arthritis: a case- contro1 study. Clin Exp Rheumato1 ; 19 :291-6,2001.
126. Boiardi L., Salvarani C., Casali B., et al: Intercellular adhesion molecule-1 gene
po1ymorphisms in Behcet's disease. J Rheumato1; 28 :1283-7,2001.
127. Fomaciari G., Salvarani C., Be1trami M., et al : Musco1oske1eta1 manifestations in
inflammatory bowe1 disease. Can J Gastroentero1; 15 :399-403,2001.
128. Gonzalez-Gay MA., Garcia-Porrua C., Pujo1 RM., Salvarani C. : Erythema nodosum
: a clinica1 approach. C1in Exp Rheumato1; 19 :365-8,2001.
129. Salvarani C., Boiardi L., Mantovani V., et al: Association of MICA alleles and HLAB51 in Italian patients with Behcet's disease. JRheumato1; 28 :1867-70,2001.
130. Olivieri I., Salvarani C., Cantini F., et al: Anky1osing spondy1itis and undifferentiated
spondy1oarthropathies : a c1inica1 review and description of a disease subset with older
12
13
age at onset. Curr Opin Rheumatol ; 13 :280-4,2001.
131. Salvarani C., Macchioni P., 01ivieri I., et al : A comparison of cyc1osporine,
sulfasalazine, and symptomatic therapy in the treatment ofpsoriatic arthritis. J Rheumato1;
28 :2274-82,2001.
132. Ghirarduzzi A., Galimberti D., Salvarani C., et al: Left atrial thrombosis in patients
with antiphospho1ipid antibody syndrome and mesenchyma1 abnormal septum. Ita1 Heart
Supp1 ; 2 : 1111-6, 200 l.
133. 01ivieri I., Padu1a A., Salvarani C., et al: Retroca1canea1 bursitis in po1ymya1gia
rheumatica. Ann Rheum Dis ; 60:1160- l, 200 l.
134. Salvarani C., Vlachonikolis IG., van der Heijde DM., et al : Muscu1oskeleta1
manifestations in a popu1ation-based cohort of inflammatory bowel disease patients.
Scand J Gastroenterol ; 36 : 1307-13, 200 l.
135. Cantini F., Nicco1i L., Salvarani C., et al: Treatment oflongstanding active giant cell
arteritis with infliximab : report of four cases. Arthritis Rheum ; 44 :2933-5,2001.
136. 01ivieri I., Padu1a A., Salvarani C., et al: Successfu1 treatment of SAPHO syndrome
with infliximab : report of two cases. Ann Rheum Dis; 61 :375-6,2002.
137. Palazzi C., 01ivieri I., Petricca A., Salvarani C. : Rheumatoid arthritis or psoriatic
symmetric po1yarthritis? A difficu1t differential diagnosis. C1in Exp Rheumatol ; 20 :3-4,
2002.
138. Salvarani C., Boiardi L., Casali B., et al: Endothelial nitric oxide synthase gene
po1ymorphisms in Behcet's disease. J Rheumato1 ; 29 :535-40, 2002.
139. Cutolo M., Straub RH., Salvarani C., et al: Adrenal gland hypofunction in active
polymyalgia rheumatica. Effect of glucocorticoid treatment on adrenal hormones and
interleukin-6. J Rheumatol ; 29 :748-56, 2002.
140. Piccoli GB., Quaglia M., Salvarani C., et al: Ankylosing spondylitis : a difficult
diagnosis in patients on long-tenn renal replacement therapy. J Nephrol ; 15 : 177 -82,
2002.
141. Palazzi C., Olivieri I., Salvarani C., et al: Reactive arthritis : advances in diagnosis
and treatment. Reumatismo; 54 :105-12, 2002.
142. Niccoli L., Salvarani C., Baroncelli G., et al: Renal celI carcinoma mimicking
polymyalgia rheumatica. Clues far a correct diagnosis. Scand J Rheumatol; 31 :1036,2002.
143. Cutolo M., Sulli A., Salvarani C., et al: Cortisol dehydroepiandrosterone sulfate, and
androstenedione levels in patients with polymyalgia rheumatica during twelve months of
glucocorticoid therapy. Ann N Y Acad Sci; 966-91 :91, 2002.
13
14
144. Salvarani C., Cantini F., Boiardi L., Hunder GG .: Polymyalgia rheumatica and giant
celI arteritis. N Engl J Med ; 347 :261-71,2002.
145. Salvarani C., Silingardi M., Ghirarduzzi A., et al: Is duplex ultrasonography useful far
the diagnosis of giant-cell arteritis? Ann Intern Med; 137 :232-8,2002.
146. Olivieri I., Salvarani C., Cantini F., et al : Fast spin echo- T2 weighted sequences with
fat saturation in dactylitis of spondylarthritis. No evidence of entheseal involvement of the
flexor digitorum tendons. Arthritis Rheum ; 46 :2964-7, 2002.
147. Salvarani C., Fametti E., Casali B., et al: Detection of parvovirus B19 DNA by
polymerase chain reaction in giant cell arteritis :a case-contraI study. Arthritis Rheum ; 46
:3099-101,2002.
148. Salvarani C., Cantini F., Olivieri I.: Disease-modifying antirheumatic drug therapy far
psoriatic arthritis. Clin Exp Rheumatol; 20 :S71-5, 2002.
149. Olivieri I., van Tubergen A., Salvarani C., van der Linden S. : Seronegative
spondyloarthritides. Best Pract Res Clin Rheumatol; 16 :723-39,2002.
150. Schirmer M., Calamia KT., Salvarani C., et al: 18F-fluorodeoxyglucose-positron
emission tomography: a new explorative perspective. Exp Gerontol ; 38 :463-70, 2003.
151. Salvarani C., Cantini F., Niccoli L., et al: Treatment of refractory polymyalgia
rheumatica with infliximab : a pilot study. J Rheumatol; 30 :760-3,2003.
152. Olivieri I., Padula A., Salvarani C., et al: Persistent efficacy of tumor necrosis factor
alpha blockage therapy in SAPHO syndrome. Arthritis Rheum; 48 : 1467,2003.
153. Salvarani C., Cantini F., Olivieri I., et al : Efficacy of infliximab in resistant psoriatic
arthritis. Arthritis Rheum ; 49 :541-5,2003.
154. Boiardi L., Casali B., Salvarani C., et al: Vascular endothelial growth factor gene
polymorphisms in giant celI arteritis. J Rheumatol ; 30 :2160-4,2003.
155. Salvarani C., Casali B., Nicoli D., et al: Endothelial nitric oxide synthase gene
polymorphisms in giant celI arteritis. Arthritis Rheum; 48 :3219-23,2003.
156. Cantini F., Salvarani C., Niccoli L., et al: Fat suppression magnetic resonance
imaging in shoulders ofpatients with polymyalgia rheumatica. J Rheumatol; 31 :1204,2004.
157. Wenger M., Calamia KT., Salvarani C., et al: Do we need 18F-FDG-positron
emission tomography as a functional imaging technique far diagnosing large vessel
arteritis? Clin Exp Rheumatol ; 21 :SI-2, 2003.
158. Salvarani C., Cantini F., Boiardi L., Hunder GG. : Laboratory investigations useful in
giant celI arteritis and Takayasu' s arteritis. Clin Exp Rheumatol ; 21 :S23-8, 2003.
14
15
159. Gonzalez-Gay MA., Garcia-Porrua C., Salvarani C., et al. Cutaneous vasculitis : a
diagnostic approach. Clin Exp Rheumatol; 21 :S85-8, 2003.
160. Salvarani C. : Large vessel vasculitis. Clin Exp Rheumatol ; 21 :SI33-4, 2003.
161. Olivieri I., Salvarani C., Cantini F., et al : Recommendations for starting anti- TNFalpha in patients with ankylosing spondylitis. Reumatismo; 55 :220-3,2003.
162. Gonzalez-Gay MA., Boiardi L., Salvar'ani C., et al: Geographical and genetic factors
do not account for significant differences in the clinical spectrum of giant cell arteritis in
southern Europe. J Rheumatol ; 31 :520-3, 2004.
163. Silingardi M., Salvarani C., Boiardi L., et al: Factor VI Leiden and prothrombin gene
G20210A mutations in Italian patients with Behcet's disease and deep vein thrombosis.
Arthritis Rheum; 51 :177-83,2004.
164. Salvarani C., Crowson CS., O'Fallon WM., et al: Reappraisal of the epidemiology of
giant celI arteritis in Olmsted County, Minnesota over a fifty-year period Arthritis Rheum ;
51 :264-8, 2004.
165. Cantini F., Niccoli L., Salvarani C., et al: Are polymyalgia rheumatica and giant celI
arteritis the same disease ? Semin Arthritis Rheum ; 33 :294-301,2004.
166. Pulsatelli L., Dolzani P., Salvar ani C., et al. Soluble receptor activator of nuclear
factor-kappaB Ligand (sRANK)/osteoprotogerin balance in ageing and age-associated
diseases. Biogerontology ; 5 : 119-27,2004.
167. Cimmino MA, Macchioni P, Salvarani C, et al : Pulse steroid treatment of polymyalgia
rheumatica. Clin Exp Rheumatol; 22 :381-2,2004.
168. Salvarani C, Boiardi L, Casali B, Olivieri I, Cantini F, Salvi F, Malatesta R, La Corte
R, Triolo G, Ferrante A, Filippini D, Paolazzi G, Sarzi-Puttini P, Nicoli D, Farnetti E, Chen
Q, Pulsatelli L. Vascular endothelial growth factor gene polymorphisms in Behcet's
disease.J Rheumatol. 2004; 31:1785-9.
169. Salvarani C, Olivieri I, Cantini F, Marchesoni A, Punzi L, Scarpa R, Matucci-Cerinic
M. [Recommendations for the appropriate use of anti-TNFalpha therapy in patients with
psoriatic arthritis. Italian Rheumatology Society.] Reumatismo. 2004; 56:133-4
170. Pipitone N, Boiardi L, Olivieri I, Cantini F, Salvi F, Malatesta R, La Corte R, Triolo G,
Ferrante A, Filippini D, Paolazzi G, Sarzi-Puttini P, Restuccia G, Salvarani C. Clinical
manifestations of Behcet's disease in 137 Italian patients: results of a multicenter
study.Clin Exp Rheumatol. 2004;22 ( Suppl 36):S46-51.
171. Silingardi M, Iotti M, Trenti C, Salvarani C, Iori I. Thalidomide, deep venous
thrombosis and vasculitis. J Thromb Haemost. 2004;2:2062-3.
172. Klauser A, Bollow M, Calin A, Frauscher F, Kainberger F, Moncayo R, Salvarani C,
Sieper J, zur Nedden D, Schirmer M. Workshop report: clinical diagnosis and imaging of
sacroiliitis, Innsbruck, Austria, October 9, 2003. J Rheumatol. 2004;31:2041-7.
15
16
173. Caporali R, Cimmino MA, Ferraccioli G, Gerli R, Klersy C, Salvarani C, Montecucco
C; Systemic Vasculitis Study Group of the Italian Society for Rheumatology. Prednisone
plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebocontrolled trial. Ann Intern Med. 2004;141:493-500.
174. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica. Best Pract
Res Clin Rheumatol. 2004;18:705-22.
175. Calin A, Dijkmans BA, Emery P, Hakala M, Kalden J, Leirisalo-Repo M, Mola EM,
Salvarani C, Sanmarti R, Sany J, Sibilia J, Sieper J, van der Linden S, Veys E, Appel AM,
Fatenejad S. Outcomes of a multicentre randomised clinical trial of etanercept to treat
ankylosing spondylitis.Ann Rheum Dis. 2004; 63:1594-600.
176. Salvarani C, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, Cimino L,
Bajocchi G, Catanoso MG, Boiardi L. Interleukin-6 promoter polymorphism at position 174 in giant cell arteritis. J Rheumatol. 2005;32:2173-7.
177. Atzeni F, Sarzi-Puttini P, Doria A, Boiardi L, Pipitone N, Salvarani C. Behcet's
disease and cardiovascular involvement. Lupus. 2005;14:723-6.
178. Benucci M, Del Rosso A, Li Gobbi F, Manfredi M, Cerinic MM, Salvarani C.
Systemic lupus erythematosus (SLE) in Italy: an Italian prevalence study based on a twostep strategy in an area of Florence (Scandicci-Le Signe). Med Sci Monit. 2005;11:CR4205.
179. Cantini F, Niccoli L, Nannini C, Padula A, Olivieri I, Boiardi L, Salvarani C.
Inflammatory changes of hip synovial structures in polymyalgia rheumatica.Clin Exp
Rheumatol. 2005;23:462-8.
180. Vaglio A, Greco P, Versari A, Filice A, Cobelli R, Manenti L, Salvarani C, Buzio C.
Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease
or silent "scar" ? A study using 18F-fluorodeoxyglucose positron emission tomography.
Clin Exp Rheumatol. 2005;23:231-4.
181. Pipitone N, Boiardi L, Salvarani C. Are steroids alone sufficient for the treatment of
giant cell arteritis? Best Pract Res Clin Rheumatol. 2005;19:277-92.
182. Salvarani C, Cimino L, Macchioni P, Consonni D, Cantini F, Bajocchi G, Pipitone N,
Catanoso MG, Boiardi L. Risk factors for visual loss in an Italian population-based cohort
of patients with giant cell arteritis. Arthritis Rheum. 2005;53:293-7.
183. Salvarani C, Pipitone N, Versari A, Vaglio A, Serafini D, Bajocchi G, Salvo D, Buzio
C, Greco P, Boiardi L. Positron emission tomography (PET): evaluation of chronic
periaortitis.Arthritis Rheum. 2005;53:298-303.
184. Vanoli M, Daina E, Salvarani C, Sabbadini MG, Rossi C, Bacchiani G, Schieppati A,
Baldissera E, Bertolini G; Itaka Study Group. Takayasu's arteritis: A study of 104 Italian
patients. Arthritis Rheum. 2005;53:100-7.
16
17
185. Salvarani C, Cantini F, Niccoli L, Macchioni P, Consonni D, Bajocchi G, Vinceti M,
Catanoso MG, Pulsatelli L, Meliconi R, Boiardi L. Acute-phase reactants and the risk of
relapse/recurrence in polymyalgia rheumatica: a prospective followup study. Arthritis
Rheum. 2005; 53:33-8.
186. Vaglio A, Versari A, Fraternali A, Ferrozzi F, Salvarani C, Buzio C. (18)Ffluorodeoxyglucose positron emission tomography in the diagnosis and followup of
idiopathic retroperitoneal fibrosis. Arthritis Rheum. 2005;53:122-5.
187. Pipitone N, Salvarani C. Systemic vasculitis: state of the art and emerging concepts.
Curr Opin Rheumatol. 2006;18:1-2.
188. Pipitone N, Olivieri I, Cantini F, Triolo G, Salvarani C. New approaches in the
treatment of Adamantiades-Behçet's disease. Curr Opin Rheumatol. 2006;18:3-9.
189. Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006; 367:241-51.
190. Martorana D, Vaglio A, Greco P, Zanetti A, Moroni G, Salvarani C, Savi M, Buzio C,
Neri TM. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin.
Arthritis Rheum. 2006;55:126-30.
191. Griffiths CE, Iaccarino L, Naldi L, Olivieri I, Pipitone N, Salvarani C, Doria A. Psoriasis
and psoriatic arthritis: immunological aspects and therapeutic guidelines. Clin Exp
Rheumatol. 2006;24(1 Suppl 40):S72-8.
192. Salvarani C, Olivieri I, Pipitone N, Cantini F, Marchesoni A, Punzi L, Scarpa R,
Matucci-Cerinic M; Italian Society for Rheumatology. Recommendations of the Italian
Society for Rheumatology for the use of biologic (TNF-alpha blocking) agents in the
treatment of psoriatic arthritis. Clin Exp Rheumatol. 2006;24:70-8.
193. Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Cantini F, Macchioni P, Bajocchi
G, Catanoso MG, Pulsatelli L, Consonni D, Salvarani C. Relationship Between Interleukin
6 Promoter Polymorphism at Position -174, IL-6 Serum Levels, and the Risk of
Relapse/Recurrence in Polymyalgia Rheumatica. J Rheumatol. 2006; 33: 703-8.
194. Chen Q, Casali B, Pattacini L, Boiardi L, Salvarani C. Tumor necrosis factor-alpha
protects synovial cells from nitric oxide induced apoptosis through phosphoinositide 3kinase Akt signal transduction. J Rheumatol. 2006; 33: 1061-8.
195. Pipitone N, Masini L, Salvarani C. A case of arthritis and vasculitis associated with
the refractory anemia with excess of blasts syndrome resistant to glucocorticoid treatment
that responded favorably to TNF-alpha blockade. Clin Exp Rheumatol. 2006;24 (2 Suppl
41):S31-4.
196. Pipitone N, Boiardi L, Bajocchi G, Salvarani C. Long-term outcome of giant cell
arteritis. Clin Exp Rheumatol. 2006; 24 (2 Suppl 41): S65-70.
197. Cantini F, Niccoli L, Benucci M, Chindamo D, Nannini C, Olivieri I, Padula A,
Salvarani C. Switching from infliximab to once-weekly administration of 50 mg etanercept
in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week
17
18
study. Arthritis Rheum. 2006;55:812-6.
198. Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, Cimino L, Bajocchi
G, Grazia Catanoso M, Pattacini L, Salvarani C. Interleukin-10 promoter polymorphisms in
giant cell arteritis. Arthritis Rheum. 2006; 54: 4011-7.
199. Salvarani C, Giannini C, Miller DV, Hunder G. Giant cell arteritis: Involvement of
intracranial arteries. Arthritis Rheum. 2006;55:985-9.
200. Pulsatelli L, Dolzani P, Silvestri T, De Giorgio R, Salvarani C, Macchioni P, Frizziero
L, Meliconi R. Synovial expression of vasoactive intestinal peptide in polymyalgia
rheumatica.Clin Exp Rheumatol. 2006 Sep-Oct;24(5):562-6.
201. Salvarani C, Pipitone N, Catanoso MG, Cimino L, Tumiati B, Macchioni P, Bajocchi
G, Olivieri I, Boiardi L. Epidemiology and clinical course of Behcet's disease in the Reggio
Emilia area of Northern Italy: A seventeen-year population-based study. Arthritis Rheum.
2007; 57:171-8.
202. Ghinoi A, Pipitone N, Boiardi L, Pizzini A, Salvarani C. Primary Sjogren's syndrome
associated with chronic periaortitis. Rheumatology (Oxford). 2007; 46: 719-20.
203. Olivieri I, Garcia-Porrua C, Padula A, Cantini F, Salvarani C, Gonzalez-Gay MA. Late
onset undifferentiated spondyloarthritis presenting with polymyalgia rheumatica features:
description of seven cases. Rheumatol Int. 2007; 27:927-33.
204. Bajocchi G, Zamorani G, Cavazza A, Pipitone N, Versari A, Boiardi L, Salvarani C.
Giant-cell arteritis of the female genital tract associated with occult temporal arteritis and
FDG-PET evidence of large-vessel vasculitis. Clin Exp Rheumatol. 2007; 25 Suppl 44(1):
36-39.
205. Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, Salvarani
C, Xu W, Visvanathan S, Rahman MU; Infliximab-GCA Study Group. Infliximab for
maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized
trial. Ann Intern Med. 2007;146:621-30.
206. Salvarani C, Macchioni P, Manzini C, Paolazzi G, Trotta A, Manganelli P, Cimmino
M, Gerli R, Catanoso MG, Boiardi L, Cantini F, Klersy C, Hunder GG. Infliximab plus
prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica:
a randomized trial. Ann Intern Med. 2007; 146: 631-9.
207. Niccoli L, Nannini C, Benucci M, Chindamo D, Cassarà E, Salvarani C, Cimino L,
Gini G, Lenzetti I, Cantini F. Long-term efficacy of infliximab in refractory posterior uveitis
of Behcet's disease: a 24-month follow-up study. Rheumatology (Oxford). 2007;46:1161-4.
208. Macchioni P, Nicoli D, Casali B, Catanoso M, Farnetti E, Boiardi L, Salvarani C. The
codon 72 polymorphic variants of p53 in Italian rheumatoid arthritis patients. Clin Exp
Rheumatol. 2007; 25: 416-21.
209. Pattacini L, Casali B, Boiardi L, Pipitone N, Albertazzi L, Salvarani C. Angiotensin II
protects fibroblast-like synoviocytes from apoptosis via the AT1-NF-kappaB pathway.
18
19
Rheumatology (Oxford). 2007; 46: 1252-7.
210. Pulsatelli L, Dolzani P, Silvestri T, Boiardi L, Salvarani C, Macchioni P, Facchini A,
Meliconi R. Circulating RANKL/OPG in polymyalgia rheumatica. Clin Exp Rheumatol.
2007; 25: 621-3.
211. Cantini F, Niccoli L, Nannini C, Chindamo D, Bertoni M, Cassarà E, Salvarani C.
Isolated knee monoarthritis heralding resectable non-small-cell lung cancer. A
paraneoplastic syndrome not previously described. Ann Rheum Dis. 2007; 66:1672-4.
212. Atzeni F, Boiardi L, Casali B, Farnetti E, Sarzi-Puttini P, Pipitone N, Olivieri I, Cantini
F, Salvi F, La Corte R, Triolo G, Filippini D, Paolazzi G, Salvarani C. Lack of association of
the -463 G/A myeloperoxidase promoter polymorphism with Behcet's disease in Italian
patients. Rheumatology (Oxford). 2007; 46: 1547-50.
213. Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Weigand SD, Miller DV,
Giannini C, Meschia JF, Huston J 3rd, Hunder GG. Primary central nervous system
vasculitis: analysis of 101 patients. Ann Neurol. 2007; 62:442-51.
214. Salvarani C, Casali B, Farnetti E, Pipitone N, Formisano D, Nicoli D, Macchioni P,
Cimino L, Bajocchi G, Grazia Catanoso M, Restuccia G, Ghinoi A, Boiardi L. PlA1/A2
polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic
complications in giant cell arteritis. Arthritis Rheum. 2007; 56:3502-8.
215. Catanoso MG, Macchioni P, Boiardi L, Pipitone N, Salvarani C. Treatment of
refractory polymyalgia reumatica with etanercept: an open pilot study. Arthritis Rheum.
2007; 57: 1514-9.
216. Vaglio A, Palmisano A, Corradi D, Salvarani C, Buzio C. Retroperitoneal fibrosis:
evolving concepts. Rheum Dis Clin North Am. 2007;33:803-17.
217. Salvarani C, Pipitone N, Catanoso MG. Clinical assessment in psoriatic arthritis.
Reumatismo. 2007;59 Suppl 1:68-72.
218. Pipitone N, Salvarani C. Established and new treatments of the idiopathic
inflammatory myopathies: dermatomyositis and polymyositis. Clin Exp Rheumatol.
2007;25:896-906.
219. Salvarani C, Hunder GG. Tumor necrosis factor blocking agents in polymyalgia
rheumatica and giant cell arteritis. Ann Intern Med. 2008; 148:167-8.
220. Salvarani C, Brown RD, Calamia KT, Huston III J, Meschia JF, Giannini C, Miller DV,
Hunder GG. Efficacy of TNF-α blockade in primary central nervous system vasculitis
resistant to immunosuppressive treatment. Arthritis Rheum 2008; 59:291-6.
221. Salvarani C, Brown RD, Calamia KT, Christianson TJH, Huston III J, Meschia JF,
Giannini C, Miller DV, Hunder GG. Primary central nervous system vasculitis with
prominent leptomeningeal enhancement. A subset with a benign outcome. Arthritis Rheum
2008; 58:595-603.
19
20
222. Pipitone N, Olivieri I, Padula A, D’Angelo S, Nigro A, Zuccoli G, Salvarani C.
Infliximab for the treatment of Neuro-Behçet’s disease: a case series and review of the
literature. Arthritis Rheum 2008; 59:285-90.
223. Pipitone N, Salvarani C. Improving therapeutic options for patients with giant cell
arteritis. Curr Opinion Rheumatol 2008; 20:17-22.
224. Vaglio A, Palmisano A, Ferretti S, Alberici F, Casazza L, Salvarani C, Buzio C.
Peripheral inflammatory arthritis in patients with chronic periaortitis: report of five cases
and review of the literature. Rheumatology (Oxford) 2008; 47:315-8.
225. D' Angelo S, Padula A, Nigro A, Cantini F, Matucci-Cerinic M, Modena V, Punzi L,
Salvarani C, Scarpa R, Olivieri I. Italian evidence-based recommendations for the
management of ankylosing spondylitis: the 3E Initiative in Rheumatology. Clin Exp
Rheumatol. 2008; 26:1005-11.
226. Pipitone N, Salvarani C. Role of imaging in vasculitis and connective tissue diseases.
Best Pract Res Clin Rheumatol. 2008; 22:1075-91. Review.
227. Pipitone N, Macchioni P, Zuccoli G, Salvarani C. Focal myositis of the calf muscles.
Clin Exp Rheumatol. 2008; 26:970-1.
228. Pipitone N, Salvarani C. The role of infectious agents in the pathogenesis of
vasculitis. Best Pract Res Clin Rheumatol. 2008; 22:897-911. Review.
229. Salvarani C, Brown RD Jr, Huston J 3rd, Hunder GG. Prominent perivascular
enhancement in primary central nervous system vasculitis. Clin Exp Rheumatol. 2008;
26(3 Suppl 49):S111.
230. Ghinoi A, Pipitone N, Nicolini A, Salvarani C. Cranial giant cell arteritis evolving into
early large-vessel vasculitis. Clin Exp Rheumatol. 2008; 26(3 Suppl 49):S97-100.
231. Ghinoi A, Zuccoli G, Nicolini A, Pipitone N, Macchioni L, Bajocchi GL, Nicoli F,
Silingardi M, Catanoso MG, Boiardi L, Salvarani C. 1T magnetic resonance imaging in the
diagnosis of giant cell arteritis: comparison with ultrasonography and physical examination
of temporal arteries. Clin Exp Rheumatol. 2008; 26(3 Suppl 49):S76-80.
232. Vaglio A, Corradi D, Maestri R, Callegari S, Buzio C, Salvarani C. Pericarditis
heralding Erdheim-Chester disease. Circulation. 2008; 118:e511-2.
233. Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF,
Giannini C, iller DV, Hunder GG. Angiography-negative primary central nervous system
vasculitis: a syndrome involving small cerebral vessels. Medicine (Baltimore). 2008;
87:264-71.
234. Pipitone N, Ghinoi A, Versari A, Vaglio A, Palmisano A, Salvarani C. Images in
cardiovascular medicine. Chronic periaortitis. Circulation. 2008; 118:1214-6.
235. Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF,
Giannini C, Miller DV, Hunder GG. Primary central nervous system vasculitis: comparison
20
21
of patients with and without cerebral amyloid angiopathy. Rheumatology (Oxford). 2008,
47:1671-7.
236. Olivieri I, de Portu S, Salvarani C, Cauli A, Lubrano E, Spadaro A, Cantini F, Cutro
MS, Mathieu A, Matucci-Cerinic M, Pappone N, Punzi L, Scarpa R, Mantovani LG; PACE
working group.The psoriatic arthritis cost evaluation study: a cost-of-illness study on
tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to
conventional therapy. Rheumatology (Oxford). 2008; 47:1664-70.
237. Pulsatelli L, Boiardi L, Pignotti E, Dolzani P, Silvestri T, Macchioni P, Cantini F,
Salvarani C, Facchini A, Meliconi R. Serum interleukin-6 receptor in polymyalgia
rheumatica: a potential marker of relapse/recurrence risk. Arthritis Rheum. 2008;
59:1147-54.
238. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell
arteritis.Lancet. 2008; 372:234-45. Review.
239. Boehncke WH, Adebajo A, Cauli A, Nash P, Salvarani C, Kavanaugh AF. Initiative for
quality in psoriasis and psoriatic arthritis. J Rheumatol. 2008; 35:1431-3.
240. Cimmino MA, Salvarani C, Macchioni P, Gerli R, Bartoloni Bocci E, Montecucco C,
Caporali R; Systemic Vasculitis Study Group of the Italian Society for Rheumatology.
Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and
steroids. Clin Exp Rheumatol. 2008; 26:395-400.
241. Doria A, Bajocchi G, Tonon M, Salvarani C. Pre-pregnancy counselling of patients
with vasculitis. Rheumatology (Oxford). 2008; 47 Suppl 3:iii13-5. Review.
242. Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF,
Giannini C, Miller DV, Hunder GG. Primary CNS vasculitis with spinal cord involvement.
Neurology. 2008 ; 70:2394-400.
243. Olivieri I, Scarano E, Padula A, D'Angelo S, Salvarani C, Cantini F, Niccoli L, Barozzi
L. Fast spin echo-T2-weighted sequences with fat saturation in toe dactylitis of
spondyloarthritis. Clin Rheumatol. 2008; 27:1141-5.
244. Revicki DA, Luo MP, Wordsworth P, Wong RL, Chen N, Davis JC Jr; ATLAS Study
Group. Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing
spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for
ankylosing spondylitis (ATLAS). J Rheumatol. 2008; 35:1346-53.
245. Salvarani C, Pipitone N, Boiardi L, Hunder GG. Do we need treatment with tumour
necrosis factor blockers for giant cell arteritis? Ann Rheum Dis. 2008;67:577-9.
246. Cantini F, Niccoli L, Nannini C, Cassarà E, Pasquetti P, Olivieri I, Salvarani C.
Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis
requiring second-line drugs. Rheumatology (Oxford). 2008; 47:872-6.
247. Cantini F, Niccoli L, Nannini C, Bertoni M, Salvarani C. Diagnosis and treatment of
giant cell arteritis. Drugs Aging. 2008;25:281-97. Review.
21
22
248. Pipitone N, Versari A, Salvarani C. Role of imaging studies in the diagnosis and
follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford). 2008; 47:403-8.
Review.
249. Pipitone N, Salvarani C. Improving therapeutic options for patients with giant cell
arteritis. Curr Opin Rheumatol. 2008; 20:17-22. Review.
250. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH,
Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S,
Yazici H; EULAR Expert Committee. EULAR recommendations for the management of
Behçet disease. Ann Rheum Dis. 2008; 67:1656-62.
251. Pipitone N, Olivieri I, Padula A, D'angelo S, Nigro A, Zuccoli G, Boiardi L, Salvarani
C. Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the
literature. Arthritis Rheum. 2008; 59:285-90. Review.
252. Vaglio A, Palmisano A, Ferretti S, Alberici F, Casazza I, Salvarani C, Buzio C.
Peripheral inflammatory arthritis in patients with chronic periaortitis: report of five cases
and review of the literature. Rheumatology (Oxford). 2008; 47:315-8.
253. Salvarani C, Barozzi L, Cantini F, Niccoli L, Boiardi L, Valentino M, Pipitone N,
Bajocchi G, Macchioni P, Catanoso MG, Olivieri I, Hunder GG. Cervical interspinous
bursitis in active polymyalgia rheumatica. Ann Rheum Dis. 2008; 67:758-61.
254. Salvarani C, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni PL, Cimino L,
Bajocchi GL et al. -463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis.
Ann Rheum Dis 2008; 67:485-8
255. Helliwell PS, Taylor WJ; CASPAR Study Group. Treatment of psoriatic arthritis and
rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse
reactions.J Rheumatol. 2008; 35:472-6.
256. Salvarani C, Hunder GG. Tumor necrosis factor blocking agents in polymyalgia
rheumatica and giant cell arteritis.
Ann Intern Med. 2008; 148:167-8;
257. Dasgupta B, Salvarani C, Schirmer M, Crowson CS, Maradit-Kremers H, Hutchings
A, Matteson EL; members of the American College of Rheumatology Work Group for
Development of Classification Criteria for PMR. Developing classification criteria for
polymyalgia rheumatica: comparison of views from an expert panel and wider survey. J
Rheumatol. 2008; 35:270-7.
258. Lubrano E, Marchesoni A, Olivieri I, D'Angelo S, Spadaro A, Parsons WJ, Cauli A,
Salvarani C, Mathieu A, Zaccara E, Ferrara N, Helliwell PS. The radiological assessment
of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the
modified SASSS scoring methods. Clin Exp Rheumatol. 2009; 27:977-80.
259. Olivieri I, Pipitone N, D' Angelo S, Padula A, Salvarani C. Late-onset rheumatoid
arthritis and late-onset spondyloarthritis. Clin Exp Rheumatol. 2009; 27(4 Suppl 55):S139-
22
23
45.
260. Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, Cimino L, Bajocchi
GL, Catanoso MG, Pattacini L, Ghinoi A, Restuccia G, Salvarani C. Toll-like receptor 4
(TLR4) gene polymorphisms in giant cell arteritis. Clin Exp Rheumatol. 2009;27(1 Suppl
52):S40-4.
261. Boiardi L, Atzeni F, Casali B, Farnetti E, Nicoli D, Pipitone N, Catanoso MG, Olivieri I,
Cantini F, Salvi F, La Corte R, Triolo G, Filippini D, Paolazzi G, Salvarani C. Toll-like
receptor 4 (TLR4) gene polymorphisms in Italian patients with Behçet's disease. Clin Exp
Rheumatol. 2009; 27(2 Suppl 53):S43-7.
262. Ghinoi A, Boiardi L, Atzeni F, Casali B, Farnetti E, Nicoli D, Pipitone N, Olivieri I,
Cantini F, Salvi F, La Corte R, Triolo G, Filippini D, Paolazzi G, Salvarani C. Protein Z
G79A and A-13G gene polymorphisms in Italian patients with Behçet's disease. Clin Exp
Rheumatol. 2009; 27(2 Suppl 53):S23-8.
263. Marchesoni A, Altomare G, Matucci-Cerinic M, Balato N, Olivieri I, Salvarani C, Lotti
T, Scarpa R, Vena G, Valesini G, Giannetti A. An Italian shared dermatological and
rheumatological proposal for the use of biological agents in psoriatic disease. J Eur Acad
Dermatol Venereol. 2009 Oct 23. [Epub ahead of print]
264. Macchioni P, Catanoso MG, Pipitone N, Boiardi L, Salvarani C. Longitudinal
examination with shoulder ultrasound of patients with polymyalgia rheumatica.
Rheumatology (Oxford). 2009; 48:1566-9.
265. Chandran V, Gottlieb A, Cook RJ, Duffin KC, Garg A, Helliwell P, Kavanaugh A,
Krueger GG, Langley RG, Lynde C, McHugh N, Mease P, Olivieri I, Rahman P, Rosen
CF, Salvarani C, Thaci D, Toloza SM, Wong MY, Zhou QM, Gladman DD. International
multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints,
nails, and dactylitis. Arthritis Rheum. 2009; 61:1235-42.
266. Cantini F, Niccoli L, Nannini C, Cassarà E, Pasquetti P, Olivieri I, Salvarani C.
Criteria, frequency, and duration of clinical remission in psoriatic arthritis patients with
peripheral involvement requiring second-line drugs. J Rheumatol Suppl. 2009; 83:78-80.
267. Salvarani C, Boiardi L, Macchioni P, Pipitone N, Catanoso M, Pigatto P.
Multidisciplinary focus on cyclosporin A. J Rheumatol Suppl. 2009; 83:52-5.
268. Nannini C, Cantini F, Niccoli L, Cassarà E, Salvarani C, Olivieri I, Lally EV. Singlecenter series and systematic review of randomized controlled trials of malignancies in
patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis receiving
anti-tumor necrosis factor alpha therapy: is there a need for more comprehensive
screening procedures? Arthritis Rheum. 2009; 61:801-12. Review.
269. Salvarani C, Fries W. Clinical features and epidemiology of spondyloarthritides
associated with inflammatory bowel disease. World J Gastroenterol. 2009; 15:2449-55.
Review.
270. Dijkmans B, Emery P, Hakala M, Leirisalo-Repo M, Mola EM, Paolozzi L, Salvarani
C, Sanmarti R, Sibilia J, Sieper J, Van Den Bosch F, van der Heijde D, van der Linden S,
23
24
Wajdula J. Etanercept in the longterm treatment of patients with ankylosing spondylitis. J
Rheumatol. 2009; 36:1256-64.
271. Lubrano E, Marchesoni A, Olivieri I, D'Angelo S, Spadaro A, Parsons WJ, Cauli A,
Salvarani C, Mathieu A, Porter G, Helliwell PS. Psoriatic arthritis spondylitis radiology
index: a modified index for radiologic assessment of axial involvement in psoriatic arthritis.
J Rheumatol. 2009; 36:1006-11.
272. Salvarani C, Della Bella C, Cimino L, Macchioni P, Formisano D, Bajocchi G,
Pipitone N, Catanoso MG, Restuccia G, Ghinoi A, Boiardi L. Risk factors for severe cranial
ischaemic events in an Italian population-based cohort of patients with giant cell arteritis.
Rheumatology (Oxford). 2009; 48(3):250-3.
273. Lubrano E, Marchesoni A, Olivieri I, D'Angelo S, Spadaro A, Parsons WJ, Cauli A,
Salvarani C, Mathieu A, Zaccara E, Ferrara N, Helliwell PS. The radiological assessment
of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the
modified SASSS scoring methods. Clin Exp Rheumatol. 2009; 27:977-80.
274. Olivieri I, Pipitone N, D' Angelo S, Padula A, Salvarani C. Late-onset rheumatoid
arthritis and late-onset spondyloarthritis. Clin Exp Rheumatol. 2009; 27(4 Suppl 55):S13945.
275. van der Heijde D, Schiff MH, Sieper J, Kivitz AJ, Wong RL, Kupper H, Dijkmans BA,
Mease PJ, Davis JC Jr; ATLAS Study Group. Adalimumab effectiveness for the treatment
of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS
trial. Ann Rheum Dis. 2009; 68:922-9.
276. Miller DV, Salvarani C, Hunder GG, Brown RD, Parisi JE, Christianson TJ, Giannini
C. Biopsy findings in primary angiitis of the central nervous system. Am J Surg Pathol.
2009 ; 33:35-43.
277. Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, Cimino L, Bajocchi
GL, Catanoso MG, Pattacini L, Ghinoi A, Restuccia G, Salvarani C. Toll-like receptor 4
(TLR4) gene polymorphisms in giant cell arteritis. Clin Exp Rheumatol. 2009;27(1 Suppl
52):S40-4.
278. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH,
Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S,
Yazici H. Management of Behçet disease: a systematic literature review for the European
League Against Rheumatism evidence-based recommendations for the management of
Behçet disease. Ann Rheum Dis. 2009; 68:1528-34. Review.
279. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T,
Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG,
Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R; European Vasculitis
Study Group. EULAR recommendations for the management of primary small and
medium vessel vasculitis. Ann Rheum Dis. 2009; 68:310-7.
280. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T,
Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG,
Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R; European Vasculitis
24
25
Study Group. EULAR recommendations for the management of large vessel vasculitis.
Ann Rheum Dis. 2009; 68:318-23.
281. Basu N, Watts R, Bajema I, Baslund B, Bley T, Boers M, Brogan P, Calabrese L, Cid
MC, Cohen-Tervaert JW, Flores-Suarez LF, Fujimoto S, de Groot K, Guillevin L, Hatemi
G, Hauser T, Jayne D, Jennette C, Kallenberg CG, Kobayashi S, Little MA, Mahr A,
McLaren J, Merkel PA, Ozen S, Puechal X, Rasmussen N, Salama A, Salvarani C,
Savage C, Scott DG, Segelmark M, Specks U, Sunderköetter C, Suzuki K, Tesar V, Wiik
A, Yazici H, Luqmani R. EULAR points to consider in the development of classification and
diagnostic criteria in systemic vasculitis. Ann Rheum Dis. 2010 May 6. [Epub ahead of
print]
282. Cimino L, Boiardi L, Aldigeri R, Casali B, Nicoli D, Farnetti E, Salvarani C, Cirone D,
De Martino L, Pupino A, Cappuccini L. G/R 241 polymorphism of intercellular adhesion
molecule 1 (ICAM-1) is associated with Fuchs uveitis. Invest Ophthalmol Vis Sci. 2010
May 5. [Epub ahead of print]
283. Salvarani C, Calamia KT, Crowson CS, Miller DV, Broadwell AW, Hunder GG,
Matteson EL, Warrington KJ. Localized vasculitis of the gastrointestinal tract: a case
series. Rheumatology (Oxford). 2010 Apr 1. [Epub ahead of print]
284. Cimino L, Aldigeri R, Salvarani C, Zotti CA, Boiardi L, Parmeggiani M, Casali B,
Cappuccini L. The causes of uveitis in a referral centre of Northern Italy. Int Ophthalmol.
2010 Mar 14. [Epub ahead of print]
285. Spadaro A, Punzi L, Marchesoni A, Lubrano E, Mathieu A, Cantini F, Olivieri I,
Salvarani C, Scarpa R, Scrivo R, Ramonda R, Porru G, D'Angelo S, Catanoso M, Atteno
M, Valesini G. Switching from infliximab or etanercept to adalimumab in resistant or
intolerant patients with spondyloarthritis: a 4-year study. Rheumatology (Oxford) 2010;
49:1107-11.
286. Scarpa R, Altomare G, Marchesoni A, Balato N, Matucci Cerinic M, Lotti T, Olivieri I,
Vena GA, Salvarani C, Valesini G, Giannetti A. Psoriatic disease: concepts and
implications. J Eur Acad Dermatol Venereol. 2010 Feb 25. [Epub ahead of print].
287. Pattacini L, Boiardi L, Casali B, Salvarani C. Differential effects of anti-TNF-alpha
drugs on fibroblast-like synoviocyte apoptosis. Rheumatology (Oxford). 2010; 49:480-9.
288. Pipitone N, Salvarani C, Peter HH. [Chronic periaortitis]. Internist (Berl). 2010 Jan;
51:45-52. German.
289. Scarpato S, Antivalle M, Favalli EG, Nacci F, Frigelli S, Bartoli F, Bazzichi L, Minisola
G, Matucci Cerinic M; RIVIERA co-authors. Patient preferences in the choice of anti-TNF
therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study).
Rheumatology (Oxford). 2010; 49:289-94.
290. Rubbert-Roth A, Tak PP, Zerbini C, Tremblay JL, Carreño L, Armstrong G, Collinson
N, Shaw TM; MIRROR Trial Investigators. Efficacy and safety of various repeat treatment
dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase
III randomized study (MIRROR). Rheumatology (Oxford) 2010; 49:1683-93.
25
26
291. Dejaco C, Duftner C, Cimmino MA, Dasgupta B, Salvarani C, Crowson CS, MaraditKremers H, Hutchings A, Matteson EL, Schirmer M; and members of the International
Work Group for PMR and GCA.
Definition of remission and relapse in polymyalgia rheumatica: data from a literature
search compared with a Delphi-based expert consensus. Ann Rheum Dis. 2010 Dec 14.
[Epub ahead of print] PMID: 21097803.
292. Hunder GG, Salvarani C, Brown RD Jr. Primary central nervous system vasculitis: Is
it a single disease? Ann Neurol 2010; 68:573-4.
293. Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF,
Giannini C, Miller DV, Hunder GG. Rapidly progressive primary central nervous system
vasculitis. Rheumatology (Oxford) 2010 Oct 19. [Epub ahead of print] PMID: 20959356.
294. Ghinoi A, Zuccoli G, Pipitone N, Salvarani C. Anti-neutrophil cytoplasmic antibody
(ANCA)-associated vasculitis involving the central nervous system: case report and review
of the literature.
Clin Exp Rheumatol 2010; 28:759-66. Epub 2010 Oct 22. Review.
PMID: 20822714.
295. Pulsatelli L, Peri G, Macchioni P, Boiardi L, Salvarani C, Cantini F, Mantovani A,
Meliconi R. Serum levels of long pentraxin PTX3 in patients with polymyalgia rheumatica.
Clin Exp Rheumatol 2010; 28:756-8. Epub 2010 Oct 22.
PMID: 20822713.
296. Magnani A, Pattacini L, Boiardi L, Casali B, Salvarani C. Reelin levels are increased
in synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 2010; 28:546-8.
Epub 2010 Aug 30. PMID: 20659411.
297. Vaglio A, Pipitone N, Salvarani C. Chronic periaortitis: a large-vessel vasculitis? Curr
Opin Rheumatol 2011; 23(1):1-6.
298. Ciccia F, Alessandro R, Rizzo A, Principe S, Raiata F, Cavazza A, Guggino G,
Accardo-Palumbo A, Boiardi L, Ferrante A, Principato A, Giardina A, De Leo G, Salvarani
C, Triolo G. Expression of interleukin-32 in the inflamed arteries of patients with giant cell
arteritis. Arthritis Rheum. 2011 Jul;63(7):2097-104. doi: 10.1002/art.30374.
299. Cauli A, Gladman DD, Mathieu A, Olivieri I, Porru G, Tak PP, Sardu C, Ujfalussy I,
Scarpa R, Marchesoni A, Taylor WJ, Spadaro A, Fernàndez-Sueiro JL, Salvarani C,
Kalden JR, Lubrano E, Carneiro S, Desiati F, Flynn JA, D'Angelo S, Vacca A, VAN Kuijk
AW, Catanoso MG, Gruenke M, Peluso R, Parsons WJ, Ferrara N, Contu P, Helliwell PS,
Mease PJ; GRAPPA 3PPsA Study Group. Patient global assessment in psoriatic arthritis:
a multicenter GRAPPA and OMERACT study. J Rheumatol. 2011 May;38(5):898-903.
Epub 2011 Feb 15.
300. Boiardi L, Vaglio A, Nicoli D, Farnetti E, Palmisano A, Pipitone N, Maritati F, Casali B,
Martorana D, Moroni G, Gallelli B, Buzio C, Salvarani C. CC chemokine receptor 5
polymorphism in chronic periaortitis. Rheumatology (Oxford). 2011 Jun;50(6):1025-32.
Epub 2011 Jan 21.
26
27
301. Salvarani C, Pipitone N, Marchesoni A, Cantini F, Cauli A, Lubrano E, Punzi L,
Scarpa R, Spadaro A, Matucci-Cerinic M, Olivieri I. Recommendations for the use of
biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for
Rheumatology.
Clin Exp Rheumatol. 2011 May-Jun;29(3 Suppl 66):S28-41. Epub 2011 Jul 26.
302. Caporali R, Conti F, Alivernini S, Atzeni F, Seriolo B, Cutolo M, Valesini G, Ferraccioli
G, Sarzi-Puttini P, Salvarani C, Guiducci S, Zampogna G, Gremese E, Pipitone N, Scrivo
R, Bugatti S, Montecucco C, Matucci-Cerinic M. Recommendations for the use of biologic
therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I.
Efficacy. Clin Exp Rheumatol. 2011 May-Jun;29(3 Suppl 66):S7-14. Epub 2011 Jul 26.
303. Restuccia G, Cavazza A, Boiardi L, Pipitone N, Macchioni P, Bajocchi G, Catanoso
MG, Muratore F, Ghinoi A, Magnani L, Cimino L, Salvarani C. Small-vessel vasculitis
surrounding an uninflamed temporal artery and isolated vasa vasorum vasculits of the
temporal artery: Two subsets of giant cell arteritis. Arthritis Rheum. 2011 Sep 27. doi:
10.1002/art.33362. [Epub ahead of print]
304. Sawalha AH, Hughes T, Nadig A, Yılmaz V, Aksu K, Keser G, Cefle A, Yazıcı A,
Ergen A, Alarcón-Riquelme ME, Salvarani C, Casali B, Direskeneli H, Saruhan-Direskeneli
G. A putative functional variant within the ubiquitin-associated domain-containing protein 2
gene (UBAC2) is associated with increased risk of Behçet's disease. Arthritis Rheum.
2011 Aug 30. doi: 10.1002/art.30604. [Epub ahead of print]
305. Germanò G, Versari A, Muratore F, Pipitone N, Bajocchi GL, Catanoso MG,
Salvarani C.
Isolated vasculitis of the lower extremities in a patient with polymyalgia rheumatica and
giant cell arteritis. Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S138-9. Epub 2011
May 11. No abstract available.
306. Zuccoli G, Pipitone N, Haldipur A, Brown RD Jr, Hunder G, Salvarani C.
Imaging findings in primary central nervous system vasculitis. Clin Exp Rheumatol. 2011
Jan-Feb;29(1 Suppl 64):S104-9. Epub 2011 May 11. Review.
307. Salvarani C, Valli R, Boiardi L, Pipitone N, Nicoli F, Muratore F. IgG4-associated
sclerosing mesenteritis. Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S79-80. Epub
2011 May 11.
308. Salvarani C, Pipitone N. Treatment of large-vessel vasculitis: where do we stand?
Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S3-5. Epub 2011 May 11.
309. Pipitone N, Salvarani C. Idiopathic aortitis: an underrecognized vasculitis.
Arthritis Res Ther. 2011 Jul 22;13(4):119. [Epub ahead of print]
310. Magnani L, Versari A, Salvo D, Casali M, Germanò G, Meliconi R, Pulsatelli L,
27
28
Formisano D, Bajocchi G, Pipitone N, Boiardi L, Salvarani C. .[Disease activity
assessment in large vessel vasculitis]. Reumatismo. 2011;63(2):86-90.
311. Vaglio A, Palmisano A, Alberici F, Maggiore U, Ferretti S, Cobelli R, Ferrozzi F,
Corradi D, Salvarani C, Buzio C. Prednisone versus tamoxifen in patients with idiopathic
retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet. 2011 Jul
23;378(9788):338-46. Epub 2011 Jul 4.
312. Pipitone N, Versari A, Vaglio A, Salvarani C. Role of 18F-fluorodeoxyglucose positron
emission tomography in the workup of retroperitoneal fibrosis. Clin Exp Rheumatol. 2011
Jan-Feb;29(1 Suppl 64):S72-8. Epub 2011 May 11.
313. Lubrano E, Spadaro A, Marchesoni A, Olivieri I, Scarpa R, D'Angelo S, Salvarani C,
Mathieu A, Cauli A, Ferrara N, Helliwell P. The effectiveness of a biologic agent on axial
manifestations of psoriatic arthritis. A twelve months observational study in a group of
patients treated with etanercept. Clin Exp Rheumatol. 2011 Jan-Feb;29(1):80-4. Epub
2011 Feb 23.
314. Salvarani C, Calamia KT, Matteson EL, Hunder GG, Pipitone N, Miller DV,
Warrington KJ.
Vasculitis of the gastrointestinal tract in chronic periaortitis. Medicine (Baltimore). 2011
Jan;90(1):28-39.
315. Palazzi C, Salvarani C, D'Angelo S, Olivieri I. Aortitis and periaortitis in ankylosing
spondylitis. Joint Bone Spine. 2011 Oct;78(5):451-5. Epub 2010 Dec 24.
316. Vaglio A, Pipitone N, Salvarani C. Chronic periaortitis: a large-vessel vasculitis?
Curr Opin Rheumatol. 2011 Jan;23(1):1-6. Review.
317. Dejaco C, Duftner C, Cimmino MA, Dasgupta B, Salvarani C, Crowson CS, MaraditKremers H, Hutchings A, Matteson EL, Schirmer M; International Work Group for PMR
and GCA.
Definition of remission and relapse in polymyalgia rheumatica: data from a literature
search compared with a Delphi-based expert consensus. Ann Rheum Dis. 2011
Mar;70(3):447-53. Epub 2010 Nov 19. Review.
318. Catanoso MG, Pipitone N, Magnani L, Boiardi L, Salvaranic C. New indications for
biological terapie. Intern Emerg med 2011; 6 (Suppl 1):S1-S9.
In Pubblicazione
319. Salvarani C, Brown RD Jr, Hunder GG. Primary Central Nervous System Vasculitis.
Lancet, Review.
320. Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J 3rd, Meschia JF,
28
29
Giannini C, Miller DV, Hunder GG. Primary central nervous system vasculitis presenting
with intracranial hemorrhage. Arthritis Rheum.
321. Carlo Salvarani, Robert D. Brown Jr, Gene G. Hunder. Adult primary central nervous
system vasculitis: an update. Current Opinion Rheumatol, in press.
Linee guida terapeutiche nazionali/internazionali
1. A cura del Gruppo multidisciplinare sui Farmaci Biologici in Reumatologia Regione
Emilia-Romagna. Trattamento sistemico dell’Artrite Reumatoide nell’adulto con particolare
riferimento ai farmaci biologici. Direzione Generale alla Sanità e alle Politiche Sociali,
Regione Emilia Romagna. Linee guida terapeutiche n.2, marzo 2010.
2. Olivieri I., Salvarani C., Cantini F., et al : Recommendations for starting anti- TNF-alpha
in patients with ankylosing spondylitis. Reumatismo; 55 :220-3,2003.
3. Salvarani C, Olivieri I, Cantini F, Marchesoni A, Punzi L, Scarpa R, Matucci-Cerinic M.
Recommendations for the appropriate use of anti-TNFalpha therapy in patients with
psoriatic arthritis. Italian Rheumatology Society. Reumatismo. 2004; 56:133-4
4. Salvarani C, Olivieri I, Pipitone N, Cantini F, Marchesoni A, Punzi L, Scarpa R,
Matucci-Cerinic M; Italian Society for Rheumatology. Recommendations of the Italian
Society for Rheumatology for the use of biologic (TNF-alpha blocking) agents in the
treatment of psoriatic arthritis. Clin Exp Rheumatol. 2006;24:70-8.
5. Salvarani C, Pipitone N, Marchesoni A, Cantini F, Cauli A, Lubrano E, Punzi L, Scarpa
R, Spadaro A, Matucci-Cerinic M, Olivieri I. Recommendations of the Italian Society for
Rheumatology for the use of biologic (TNF-α blocking) agents in the treatment of psoriatic
arthritis: 2009 update. Clin Exp Rheumatol, in press
6. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich
B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG, Stegeman C,
Watts R, Westman K, Witter J, Yazici H, Luqmani R; European Vasculitis Study Group.
EULAR recommendations for the management of primary small and medium vessel
vasculitis. Ann Rheum Dis. 2009; 68:310-7.
7. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich
B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG, Stegeman C,
Watts R, Westman K, Witter J, Yazici H, Luqmani R; European Vasculitis Study Group.
EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis.
2009; 68:318-23.
8. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH, Kötter
I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S, Yazici
H; EULAR Expert Committee. EULAR recommendations for the management of Behçet
disease.
Ann Rheum Dis. 2008; 67:1656-62.
Partecipazione a Textbook internazionali di Reumatologia
29
30
EULAR Compendium on Rheumatic Diseases. Pipitone N, Hazleman B, Salvarani C.
Polymyalgia rheumatica and giant cell arteritis. Editor JWJ Bijlsma. BMJ Publishing Group
and European league Against Rheumatism 2009.
Chapter: Large vessel vasculitis/giant cell arteritis. Oxford Textbook of Rheumatology 4th
edition. Editors: Richard Watts, Philip Conaghan, Christopher Denton, Helen Foster, John
Isaacs & Ulf Müller-Ladner. In press.
Progetti ricerca finalizzata 2009 finanziati:
Principale investigatore del progetto proposto dalla Regione Emilia Romagna dal titolo: “
Diagnosis and treatmet of inflammatory arthropathies in the Regione Emilia Romagna: a
prospective population-based study”.
Progetti ricerca finalizzata 2010 proposti:
Principale investigatore del progetto: Epigenetic determinants of psoriasis and psoriasi
arthritis: diagnostic and prognostic values of DNA methylation pattern
Partecipazione a corsi, congressi, convegni e seminari
Negli ultimi 10 anni ho sempre partecipato come relatore invitato ai convegni della Società
Italiana di Reumatologia (SIR), American College of Rheumatology (Società Americana di
Reumatologia) e European League Against Rheumatism (EULAR). Sono inoltre stato
invitato a parlare a numerosi corsi o seminari organizzati dalle stesse Società.
30